Amantadine

• Description :

  Amantadine (1-Adamantanamine) is an orally avtive and potent antiviral agent with activity against influenza A viruses. Amantadine inhibits several ion channels such as NMDA and M2, and also inhibits Coronavirus ion channels. Amantadine also has anti-orthopoxvirus and anticancer activity. Amantadine can be used for Parkinson's disease, postoperative cognitive dysfunction (POCD) and COVID-19 research[1][2][3][4][5][6].

• Product Name Alternative :

  1-Adamantanamine; 1-Aminoadamantane

• UNSPSC :

  12352211

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Apoptosis; Bcl-2 Family; CDK; Influenza Virus; Orthopoxvirus; SARS-CoV

• Type :

  Reference compound

• Related Pathways :

  Anti-infection; Apoptosis; Cell Cycle/DNA Damage

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Cancer; Infection; Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/amantadine.html

• Purity :

  99.90

• Solubility :

  DMSO : 6.48 mg/mL (ultrasonic; warming; adjust pH to 4 with 1 M HCl; heat to 60°C)

• Smiles :

  NC12C[C@H]3C[C@@H](C2)C[C@@H](C1)C3

• Molecular Formula :

  C10H17N

• Molecular Weight :

  151.25

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]Suzuki H, et al. Emergence of amantadine-resistant influenza A viruses: epidemiological study. J Infect Chemother. 2003;9 (3) :195-200.|[2]Hubsher G, et al. Amantadine: the journey from fighting flu to treating Parkinson disease. Neurology. 2012;78 (14) :1096-1099.|[3]Donald F Smee, et al. A review of compounds exhibiting anti-orthopoxvirus activity in animal models. Antiviral Res. 2003 Jan;57 (1-2) :41-52. |[4]Fink K, et al. Amantadine Inhibits SARS-CoV-2 In Vitro. Viruses. 2021 Mar 24;13 (4) :539. |[5]Zhang J, et al. Amantadine alleviates postoperative cognitive dysfunction possibly by increasing glial cell line-derived neurotrophic factor in rats. Anesthesiology. 2014 Oct;121 (4) :773-85.|[6]Lan Z, et al. Amantadine inhibits cellular proliferation and induces the apoptosis of hepatocellular cancer cells in vitro. Int J Mol Med. 2015;36 (3) :904-910.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, protect from light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched

• Isoform :

  Bax; Bcl-2; CDK2

• Citation 01 :

  ACS Infect Dis. 2025 Jun 13;11 (6) :1437-1447.|Emerg Microbes Infect. 2025 Dec;14 (1) :2564308.|Int J Mol Sci. 2025 Jun 3;26 (11) :5358.|Open Forum Infect Dis. 2025 Apr 10;12 (5) :ofaf212.|SSRN. 2024 Aug 7.|Virol J. 2025 Jun 4;22 (1) :181.|Chem Phys Lipids. 2024 May 11:262:105397.|Int J Nanomedicine. 2019 Nov 27;14:9217-9234.|Signal Transduct Target Ther. 2021 Mar 27;6 (1) :134.

• CAS Number :

  [768-94-5]